Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Wiley
2017
|